Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Marc Semigran > Profile

Marc Semigran

Affiliations

Chief Development Officer at Edgewise Therapeutics Inc. (EWTX), 2023-08-18
Chief Medical Officer at Renovacor Inc. (RCOR), 2022-12-06
Director at Social Capital Suvretta Holdings Corp. Iii (DNAC), 2021-06-30
Chief Medical Officer at Myokardia Inc (MYOK), 2019-02-12

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Myokardia Inc	MYOK	$60.00	3,600	Officer	0	2018-09-05	Filing
Myokardia Inc	MYOK	$59.49	41,400	Officer	0	2018-09-04	Filing